Regenxbio (RGNX) Cash & Current Investments (2014 - 2026)
Regenxbio (RGNX) recorded Cash & Current Investments of $105.52 million in Q2 2026, down 67.4% from $323.3 million a year earlier and down 29.9% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Cash & Current Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio reported Cash & Current Investments of $230.07 million, down 2.0% from FY2024.
- Annual Cash & Current Investments has declined for five straight years, with a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $234.69 million in FY2024 (-14.7%), $275.26 million in FY2023 (-24.5%), $364.64 million in FY2022 (-20.3%) and $457.44 million in FY2021 (-3.8%).
- The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q4 2016.
- On a year-over-year basis, Cash & Current Investments has declined for three consecutive quarters, with an average decline of 18.2% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 40.7% in Q3 2021, against a decline of 67.4% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $150.49 million (Q1 2026), $230.07 million (Q4 2025) and $274.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - | 250.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 250.98 Mn |
| Jun 30, 2026 | 105.52 Mn |
| Mar 31, 2026 | 150.49 Mn |
| Dec 31, 2025 | 230.07 Mn |
| Sep 30, 2025 | 274.21 Mn |
| Jun 30, 2025 | 323.30 Mn |
| Mar 31, 2025 | 267.87 Mn |
| Dec 31, 2024 | 234.69 Mn |
| Sep 30, 2024 | 255.46 Mn |
| Jun 30, 2024 | 290.36 Mn |
| Mar 31, 2024 | 338.70 Mn |
| Dec 31, 2023 | 275.26 Mn |
| Sep 30, 2023 | 301.89 Mn |
| Jun 30, 2023 | 320.08 Mn |
| Mar 31, 2023 | 331.82 Mn |
| Dec 31, 2022 | 364.64 Mn |
| Sep 30, 2022 | 382.42 Mn |
| Jun 30, 2022 | 402.96 Mn |
| Mar 31, 2022 | 394.13 Mn |
| Dec 31, 2021 | 457.44 Mn |
API Access
Regenxbio Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();